SCHEMBL7483364

SCHEMBL7483364

CCOC(=O)COc1cccc2c1CCC2O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.45
F9 P00740 1/20 0.44
ABCB1 P08183 1/20 0.43
ALDH1A1 P00352 4/20 0.42
KDM4E B2RXH2 4/20 0.42
HPGD P15428 3/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
NPSR1 Q6W5P4 2/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 2/20 0.42
POLL Q9UGP5 1/20 0.42
S1PR1 P21453 4/20 0.42
MAPT P10636 2/20 0.42
S1PR4 O95977 2/20 0.42
PTPN1 P18031 1/20 0.42
LMNA P02545 1/20 0.42
ITGA4 P13612 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24510645 0.83 S1PR1 (0.52) KMT2APOLLS1PR1MAPTS1PR4
SCHEMBL7778589 0.81 PTGIR (0.49) USP2ALDH1A1KDM4EHPGDSMN1; SMN2
SCHEMBL9005657 0.80 PTGIR (0.53) ALDH1A1KDM4EHPGDSMN1; SMN2GAA
SCHEMBL7492500 0.80 KMT2A (0.53) KMT2APOLLLMNA
SCHEMBL8524475 0.79 PTGIR (0.47) USP2ABCB1ALDH1A1KDM4EGAA
SCHEMBL5446638 0.78 KMT2A (0.47) KMT2APOLLS1PR1S1PR4MEN1
SCHEMBL1835786 0.77 KMT2A (0.50) ALDH1A1KDM4EHPGDKMT2ALMNA
SCHEMBL1835788 0.77 KMT2A (0.50) ALDH1A1KDM4EHPGDKMT2ALMNA
SCHEMBL8524473 0.77 PTGIR (0.45) USP2ABCB1ALDH1A1GAA
SCHEMBL9017276 0.76 PTGIR (0.52) ALDH1A1KDM4EHPGDSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0842161-B1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO (JP) 2002-09-18 EP disclosed
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
EP-0842161-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-20 EP disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed